JerryAMolitorMD
Rheumatology • Minneapolis, MNSpondyloarthropathy
Associate Professor, Medicine, University of Minnesota Medical School
Dr. Molitor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
516 Delaware Street SE Clinic 6a
UMP Medicine Specialties Clinic
Minneapolis, MN 55455Phone+1 612-884-0649
Education & Training
University of WashingtonFellowship, Rheumatology, 1997 - 1999- University of WashingtonResidency, Internal Medicine, 1994 - 1997
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1993
Certifications & Licensure
MN State Medical License 2007 - 2025
WA State Medical License 1997 - 2008
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2005 Dec 01
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- 177 citationsHigh-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot st...Richard A. Nash, Peter A. McSweeney, Leslie J. Crofford, Muneer H. Abidi, Chien-Shing Chen
Blood. 2007-08-15 - 121 citationsTwo-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controll...C Antoni, Arthur Kavanaugh, Désirée van der Heijde, A. Beutler, Gregory F. Keenan
The Journal of Rheumatology. 2008-05-01 - 483 citationsSustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arth...C Antoni, Arthur Kavanaugh, B. Kirkham, Zuhre Tutuncu, Gerd R Burmester
Arthritis and Rheumatism. 2005-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
